New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »Can Psychotherapy Lower Blood Sugar? New Evidence Finds a Link Between Mind and Metabolism
Discover how psychotherapy for type 2 diabetes may improve A1C, support self-management, and influence weight and metabolic health.
Read More »Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”
Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …
Read More »Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?
Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …
Read More »GLP-1s and Opioids: The GI Risk Clinicians May Be Missing
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …
Read More »Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?
Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …
Read More »A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?
A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …
Read More »Digital Diabetes Coaching: Why an App Alone Isn’t Enough
A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …
Read More »More Dietary Fat, Worse Blood Fats? A Low-Carb Diabetes Trial Challenges the Assumption
Does eating more fat automatically mean that more harmful fatty acids will circulate in the blood? A new randomized trial suggests the answer may be more complicated. Researchers studying a low-carb diet for type 2 diabetes found that six months of carbohydrate restriction changed circulating fatty acids in potentially favorable …
Read More »Beyond Blood Sugar: What Personalized Nutrition May Be Doing to Inflammation
Medical nutrition therapy for diabetes is often discussed in terms of A1C, glucose levels, and weight. However, could personalized nutrition also influence inflammation and other aspects of metabolic health? A recent randomized controlled trial offers an intriguing reason to ask that question. Researchers found that individualized medical nutrition therapy with …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.